A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

Despite advancements in therapy, pneumonia remains the leading cause of death due to infectious diseases. Novel treatment strategies are desperately needed to optimize the antimicrobial therapy of patients suffering from this disease. One such strategy that has recently garnered significant attentio...

Descripción completa

Detalles Bibliográficos
Autores principales: Biagi, Mark, Butler, David, Tan, Xing, Qasmieh, Samah, Wenzler, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466860/
https://www.ncbi.nlm.nih.gov/pubmed/30884839
http://dx.doi.org/10.3390/antibiotics8010027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466860/
https://www.ncbi.nlm.nih.gov/pubmed/30884839
http://dx.doi.org/10.3390/antibiotics8010027

Ejemplares similares